Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Cardiovasc Pathol ; 25(1): 40-6, 2016.
Article in English | MEDLINE | ID: mdl-26490693

ABSTRACT

BACKGROUND: Remodeling of extracellular matrix is a key process during wound healing, which is strictly regulated by matrix metalloproteinases (MMPs) and their tissue inhibitors [tissue inhibitors of metalloproteinases (TIMPs)]. In this study, we evaluated intrathrombotic MMPs and TIMPs and their cellular origin during thrombus evolution after disruption of coronary atherosclerotic plaque. MATERIALS AND METHODS: Thrombectomy materials (N=120) obtained from patients with acute myocardial infarction were histologically classified in three groups based on thrombus age: fresh (<1day), lytic (1-5days), or organized (>5days) thrombi; materials showing a heterogeneous composition were classified according to oldest part. Presence and cellular origin of MMPs (MMP-1, MMP-2, MMP-8, MMP-9, and MMP-14) and TIMPs (TIMP-1, TIMP-2, and TIMP-3) was evaluated with immunostains (double) and with polymerase chain reaction. RESULTS AND CONCLUSION: MMPs and TIMPs were present in all the thrombectomy samples. A distinct temporal change in extent and cellular origin of MMPs and TIMPs during thrombus evolution was observed. In the early (fresh and lytic) stages of thrombus, high numbers of neutrophilic granulocytes occupy the thrombus mass and produce large amounts of MMPs and TIMPs. However, with progression of thrombus evolution (organizing stage) and diminishment of neutrophil granulocytes, there is disappearance of MMP-8 and MMP-9, steep decline of MMP-1 and TIMP-2, and progressive decrease of TIMP-3. In contrast, intrathrombotic MMP-2 and MMP-14 are present at a constant high level during the entire process of thrombus evolution. These temporal changes indicate a complex time-dependent function of MMPs, which are largely granulocyte derived, in the healing process of thrombus after plaque disruption.


Subject(s)
Coronary Artery Disease/enzymology , Coronary Thrombosis/enzymology , Coronary Vessels/enzymology , Granulocytes/enzymology , Matrix Metalloproteinases/metabolism , Myocardial Infarction/enzymology , Biopsy , Coronary Artery Disease/genetics , Coronary Artery Disease/pathology , Coronary Artery Disease/surgery , Coronary Thrombosis/genetics , Coronary Thrombosis/pathology , Coronary Thrombosis/surgery , Coronary Vessels/pathology , Coronary Vessels/surgery , Gene Expression Regulation, Enzymologic , Granulocytes/pathology , Humans , Immunohistochemistry , Matrix Metalloproteinases/genetics , Myocardial Infarction/genetics , Myocardial Infarction/pathology , Myocardial Infarction/surgery , Plaque, Atherosclerotic , Reverse Transcriptase Polymerase Chain Reaction , Thrombectomy , Time Factors , Tissue Inhibitor of Metalloproteinases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...